105-7100-060
Medtronic Onyx 18 Liquid Embolic System w/Onyx LES, DMSO & Syringes
$2,999.00
kits
Out of stock
Expiration:
In-Date
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
We currently do not have this item in stock, but we can email you as soon as it is available!
Ethibond green 30" C-1 taper
$286.00 box of 36
Medtronic Monosof clear 18" P-13 cutting
$1.00 packets
Medtronic Polysorb undyed 18" P-10 cutting
$10.00 packets
Vicryl violet 27" CP-1 cutting
$171.00 box of 36
Medtronic Surgipro blue 36" V-20 taper, double armed
$3.00 packets
Ethilon black 5" V75-3 tapercutting
$41.00 packets
Description
Onyx® LES
Onyx® is a non-adhesive liquid embolic agent used for the pre-surgical embolization of brain Arteriovenous malformations (bAVM).
- Onyx is comprised of EVOH (ethylene vinyl alcohol) copolymer dissolved in DMSO (dimethyl sulfoxide), and suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy.
- The Onyx Liquid Embolic System (LES) consists of a 1.5 ml vial of Onyx, a 1.5 ml vial of DMSO, and three 1 ml Onyx delivery syringes.
- A DMSO compatible delivery micro catheter that is indicated for use in the neuro vasculature (e.g. Marathon™, Rebar® or UltraFlow™ HPC catheters) is used to access the embolization site.
- Onyx is available in two product formulations, Onyx 18 (6% EVOH) and Onyx 34 (8% EVOH).
- Onyx 18 will travel more distally and penetrate deeper into the nidus due to its lower viscosity compared to Onyx 34.
- Final solidification occurs within five minutes for both product formulations.
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Unit | kits |
- FDA Product Code: MFE
- FDA Product Code Name: Agent, injectable, embolic
- GMDN Term Code: 60939
- GMDN Term Name: Neurovascular embolization plug
- GMDN Term Description: A non-bioabsorbable material (e.g., gel, liquid) intended to be implanted in a neurovascular blood vessel, to obstruct blood flow to treat a brain arteriovenous malformation (bAVM). It may be supplied as a liquid [e.g., ethylene vinyl alcohol (EVOH)], gel or powder intended to solidify or expand in situ to create a barrier to blood flow (embolus); it contains no pharmaceutical agents. It may be supplied with dedicated instruments for implantation.
